CliffBio
small molecule

CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES

FEXOFENADINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameCHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
Active ingredientFEXOFENADINE HYDROCHLORIDE
Strength30MG/5ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2017
Marketing statusOTC

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.